ZNF585B Inhibitors
Regarding the category of ZNF585B Inhibitors, these compounds offer a wide spectrum of inhibitory action targeted at cellular processes or signaling pathways where ZNF585B is postulated to function. Agents like FK506 and Calyculin A focus on the phosphorylation status of proteins, offering a route to modulate ZNF585B's function if it is post-translationally modified by phosphorylation or dephosphorylation. In addition, compounds like Rapamycin and Ionomycin explore the avenues of nutrient sensing and calcium signaling, which are vital in cell growth, differentiation, and apoptosis.
Similarly, inhibitors that target specific kinases and phosphatases, such as Staurosporine and Okadaic Acid, provide a broader spectrum of action. These agents can offer crucial insights into ZNF585B's functional relationships within these pathways. For instance, if ZNF585B is identified to function in the Ras-Raf-MEK-ERK pathway, PD0325901 could provide a direct mechanism to inhibit its activity by targeting MEK, thereby derailing the entire signaling cascade downstream. Therefore, the strategic use of these inhibitors can decode the operational complexity of ZNF585B within these pathways, offering a precise approach to modulate its activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK506 inhibits calcineurin, a phosphatase that could dephosphorylate proteins in pathways that ZNF585B is involved in. By inhibiting calcineurin, FK506 can maintain the phosphorylated state of such proteins, affecting their activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases 1 and 2A. If ZNF585B's function is regulated by these phosphatases, Calyculin A can affect its activity by preventing dephosphorylation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in cell growth and autophagy. This can indirectly affect ZNF585B if it operates downstream or in parallel pathways to mTOR. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which could affect various signaling pathways. If ZNF585B is calcium-responsive, its activity can be modulated. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole interferes with microtubule polymerization. If ZNF585B is involved in processes like cell division where microtubules play a role, its function could be affected. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that affects multiple kinases, thereby potentially affecting ZNF585B's activity if it operates in kinase-dependent pathways. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose inhibits glycolysis, which can indirectly affect ZNF585B if it is involved in metabolic regulation. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT inhibits gamma-secretase, affecting Notch signaling. If ZNF585B is part of this pathway, its function could be altered. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone inhibits GSK-3β and cyclin-dependent kinases. This can affect ZNF585B if it is involved in Wnt signaling or cell cycle regulation. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Manumycin A inhibits farnesyl transferase, affecting Ras signaling. If ZNF585B is involved in Ras-dependent processes, its function can be inhibited. | ||||||